Lab tools & diagnostics
Instruments, supplies and testing services for labs, drugmakers and doctors.
Bir yapay zekâ modelinin yardımıyla gruplandı ve editörlerimizce gözden geçirildi. Her şirketin altındaki satır, neden burada olduğunu söyler.
Hisse fiyatları 11 Kas 2026 kapanış fiyatlarıdır, IEX borsa verisinden.
Grade mix
A 8B 8C 2D 1F 1
Revenue growing
19 of 20
Free cash flow growing
9 of 20
Median price move, 1 year
+%22,0
TMOTHERMO FISHER SCIENTIFIC INC.Diagnostics and researchMarket cap $265,9BP/E 37,85
$717,62+%22,51YSince added +%8,2
A+- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- Hızlanıyor
- Business quality
- Güçlü
- Getting better
- İyileşiyor
Revenue
$47,4B+%8,3Profit
$7,1B+%7,6Free cash flow
$7,6B+%24,3Why it is here: Sells lab instruments, reagents and services to researchers and drug makers
DHRDANAHER CORPORATIONDiagnostics and researchMarket cap $165,5BP/E 38,51
$235,31+%8,01YSince added +%5,4
B+- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- Hızlanıyor
- Business quality
- Güçlü
- Getting better
- İyileşiyor
Revenue
$25,6B+%5,5Profit
$4,3B+%23,6Free cash flow
$5,7B+%14,2Why it is here: Sells research instruments, supplies and services
AAGILENT TECHNOLOGIES, INC.Diagnostics and researchMarket cap $49,9BP/E 34,89
$176,91+%17,61YSince added +%3,1
B+- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- Hızlanıyor
- Business quality
- Güçlü
- Getting better
- İyileşiyor
Revenue
$7,4B+%8,6Profit
$1,4B+%18,0Free cash flow
$1,3B+%16,5Why it is here: Sells lab instruments, consumables and software to labs and drug makers
WATWaters CorporationDiagnostics and researchMarket cap $46,3BP/E 202,08
$470,84+%21,51YSince added +%9,7
D- Büyüme ve nakit
- Büyüyor
- Business trend
- Yavaşlıyor
- Business quality
- Karışık
- Getting better
- Karışık
Revenue
$5,6B+%84,2Profit
$98,6M-%84,8Free cash flow
$290,8M-%51,7Why it is here: Sells liquid chromatography and mass spectrometry instruments and consumables
MTDMettler-Toledo International Inc.Diagnostics and researchMarket cap $34,8BP/E 37,95
$1.749,30+%20,81YSince added +%9,4
B+- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- İstikrarlı
- Business quality
- Güçlü
- Getting better
- İyileşiyor
Revenue
$4,2B+%6,5Profit
$934,1M+%11,8Free cash flow
$870,6M-%2,1Why it is here: Makes precision laboratory instruments and weighing equipment
ILMNIllumina, Inc.Diagnostics and researchMarket cap $32,2BP/E 36,64
$212,86+%74,51YSince added -%21,5
A+- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- İstikrarlı
- Business quality
- Güçlü
- Getting better
- Belirgin biçimde iyileşiyor
Revenue
$4,5B+%5,8Profit
$895M+%27,5Free cash flow
$1,1B+%5,7Why it is here: Sells DNA sequencing instruments and reagents
IDXXIDEXX LABORATORIES INC /DEDiagnostics and researchMarket cap $55,4BP/E 47,37
$703,00-%1,51YSince added +%35,2
A+- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- İstikrarlı
- Business quality
- Güçlü
- Getting better
- Belirgin biçimde iyileşiyor
Revenue
$4,7B+%11,9Profit
$1,2B+%15,1Free cash flow
$1,3B+%35,3Why it is here: Sells veterinary diagnostic tests and instruments
DGXQuest Diagnostics IncDiagnostics and researchMarket cap $28,5BP/E 25,77
$258,72+%40,81YSince added +%12,2
A- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- İstikrarlı
- Business quality
- Sağlam
- Getting better
- İyileşiyor
Revenue
$11,8B+%9,1Profit
$1,1B+%16,5Free cash flow
$1,4B-%1,3Why it is here: Provides diagnostic testing and clinical lab services
LHLABCORP HOLDINGS INC.Diagnostics and researchMarket cap $30,2BP/E 30,53
$372,18+%41,31YSince added +%18,7
A- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- İstikrarlı
- Business quality
- Karışık
- Getting better
- Belirgin biçimde iyileşiyor
Revenue
$14,6B+%6,0Profit
$1B+%17,4Free cash flow
$1,3B-%6,8Why it is here: Provides diagnostic tests and clinical lab services
RVTYREVVITY, INCDiagnostics and researchMarket cap $17,7BP/E 70,32
$158,22+%68,51YSince added +%2,0
A- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- İstikrarlı
- Business quality
- Karışık
- Getting better
- İyileşiyor
Revenue
$2,9B+%4,6Profit
$253,2M+%6,6Free cash flow
$590,5M+%18,7Why it is here: Sells lab instruments, reagents and diagnostics tools to research and drug makers
IQVIQVIA HOLDINGS INC.Diagnostics and researchMarket cap $45,2BP/E 33,38
$274,37+%24,21YSince added +%5,2
A- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- İstikrarlı
- Business quality
- Karışık
- Getting better
- İyileşiyor
Revenue
$17,3B+%8,8Profit
$1,4B+%8,7Free cash flow
$2,1B-%6,0Why it is here: Runs clinical trials and sells healthcare data to drugmakers
NTRANATERA, INC.Diagnostics and researchMarket cap $46,4BF/K yok (faaliyet zararı)
$319,77+%52,61YSince added -%19,2
B-- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- İstikrarlı
- Business quality
- Zayıf
- Getting better
- Karışık
Revenue
$2,9B+%37,4Profit
-$164,7M+%46,7Free cash flow
$52,5M-%50,5Why it is here: Provides genetic and cell-free DNA diagnostic tests
TECHBIO-TECHNE CorpBiotechnologyMarket cap $11,4BP/E 66,77
$72,78+%19,21YSince added +%0,4
A+- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- Hızlanıyor
- Business quality
- Güçlü
- Getting better
- Belirgin biçimde iyileşiyor
Revenue
$1,2B+%0,9Profit
$172M+%120,5Free cash flow
$308,2M+%37,6Why it is here: Sells proteins, antibodies and diagnostic reagents to researchers
BRKRBRUKER CORPORATIONMedical devicesMarket cap $9,5BF/K yok (faaliyet zararı)
$62,41+%47,51YSince added +%11,0
B- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- Yavaşlıyor
- Business quality
- Karışık
- Getting better
- Karışık
Revenue
$3,5B+%2,2Profit
-$123,4M-%490,4Free cash flow
$244,7M+%2.408,5Why it is here: Makes scientific instruments for microscopy, spectroscopy and magnetic resonance research
RGENREPLIGEN CORPMedical instruments and suppliesMarket cap $9,8BNo P/E
$172,68+%9,31YSince added -%1,6
B- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- Yavaşlıyor
- Business quality
- Karışık
- Getting better
- İyileşiyor
Revenue
$805,6M+%13,8Profit
-$11,8M-%779,2Free cash flow
$106,7M-%3,0Why it is here: Supplies bioprocessing filtration, chromatography and protein products to biologic drug makers
BIOBIO-RAD LABORATORIES, INC.Medical devicesMarket cap $10,4BF/K yok (faaliyet zararı)
$386,08+%18,01YSince added +%6,1
C- Büyüme ve nakit
- Büyüyor
- Business trend
- İstikrarlı
- Business quality
- Sağlam
- Getting better
- İyileşiyor
Revenue
$2,6B+%1,4Profit
$1B+%251,3Free cash flow
$329,1M-%2,3Why it is here: Sells life science research tools and clinical diagnostics reagents and instruments
QGENQIAGEN N.V.Diagnostics and researchMarket cap $10,9BP/E 25,93
$50,30+%19,81YSince added +%10,7
B+- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- İstikrarlı
- Business quality
- Güçlü
- Getting better
- İyileşiyor
Revenue
$2,1B+%2,1Profit
$384,5M-%5,2Free cash flow
$436,2M-%8,9Why it is here: Supplies sample preparation and molecular testing kits and instruments
GHGUARDANT HEALTH, INC.Diagnostics and researchMarket cap $20,9BF/K yok (faaliyet zararı)
$154,76+%58,21YSince added -%4,5
B- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- İstikrarlı
- Business quality
- Karışık
- Getting better
- Karışık
Revenue
$1,3B+%41,7Profit
-$485,1M-%21,6Free cash flow
-$232,1M+%11,5Why it is here: Provides blood-based cancer diagnostic tests
MEDPMedpace Holdings, Inc.Diagnostics and researchMarket cap $18,6BP/E 36,90
$664,52+%11,21YSince added +%9,0
C+- Büyüme ve nakit
- Güçlü büyüyor
- Business trend
- Yavaşlıyor
- Business quality
- Güçlü
- Getting better
- Belirgin biçimde iyileşiyor
Revenue
$2,8B+%20,4Profit
$517,8M+%19,6Free cash flow
$667,6M-%1,4Why it is here: Runs clinical trials for biotech and pharma drug developers
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.Diagnostics and researchMarket cap $16,4BP/E 353,20
$342,61+%99,81YSince added +%14,5
F- Büyüme ve nakit
- Karışık
- Business trend
- Daralıyor
- Business quality
- Karışık
- Getting better
- Karışık
Revenue
$4B-%1,2Profit
$40,2M+%148,8Free cash flow
$399,6M-%26,5Why it is here: Provides preclinical research models and testing services to drug developers
Green and red compare each figure with the same window a year earlier. Grades and checks are the company page's own; nothing here is a recommendation.
Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.
DiscussionNo comments yet
Be civil and stick to the companies. Comments are opinions, not advice.